|
Market Closed -
Nasdaq
04:00:00 2026-11-13 pm EST
|
5-day change | 1st Jan Change | ||
| 24.60 USD | -5.53% |
|
-3.45% | +39.46% |
| Nov. 13 | Zai Lab Limited - Special Call | |
| Nov. 13 | Zai Lab Says Experimental Drug Reduced Activity of Protein Linked to Atopic Dermatitis by at Least 90% | MT |
| Market Cap | 2.77B 2.51B 2.32B 2.09B 3.94B 261B 4.08B 27.85B 11.04B 139B 10.38B 10.16B 442B | P/E 2026 * |
-13.2x | P/E 2027 * | -11.5x |
|---|---|---|---|---|---|
| Enterprise Value | 2.13B 1.93B 1.78B 1.61B 3.03B 201B 3.14B 21.42B 8.49B 107B 7.98B 7.81B 340B | EV / Sales 2026 * |
4.84x | EV / Sales 2027 * | 4.26x |
| Free-Float |
93.88% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ZLAB | Delayed | |
CBOE
| ZLAB | Real-time | |
|
Tradegate
| 1ZL | Real-time | |
|
Deutsche Boerse AG
| 1ZL | Delayed | |
|
Börse Stuttgart
| 1ZL | Delayed | |
|
Boerse Muenchen
| 1ZL | Real-time |
Last Transcript: Zai Lab Limited
| 1 day | -5.53% | ||
| 1 week | -3.45% | ||
| Current month | +11.46% | ||
| 1 month | +9.33% | ||
| 3 months | -5.02% | ||
| 6 months | +21.00% | ||
| Current year | +39.46% |
| 1 week | 23.43 |  | 29.02 |
| 1 month | 21.42 | | 29.02 |
| Current year | 15.96 | | 29.02 |
| 1 year | 15.96 | | 29.02 |
| 3 years | 13.48 | | 44.34 |
| 5 years | 13.48 | | 91.84 |
| 10 years | 13.48 | | 193.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ying Du
CEO | Chief Executive Officer | 61 | 2014-03-31 |
Ya jing Chen
DFI | Director of Finance/CFO | 58 | 2023-07-06 |
Rafael Amado
PSD | President | 62 | 2022-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ying Du
CHM | Chairman | 61 | 2014-03-31 |
John Diekman
BRD | Director/Board Member | 83 | 2016-12-31 |
Peter Wirth
BRD | Director/Board Member | 75 | 2016-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/1/26 | Exercice | Chief Financial Officer | 2,155 | 0.0002% | ||
| 8/19/26 | Sell | Chief Financial Officer | -260 | 0.0000% | ||
| 8/14/26 | Exercice | Chief Financial Officer | 2,927 | 0.0003% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.53% | -3.45% | +13.10% | -13.20% | 2.77B | |
| +1.26% | +6.61% | +40.79% | +136.32% | 1,286B | |
| +0.79% | +3.45% | +45.84% | +93.52% | 688B | |
| +0.20% | +1.28% | +26.97% | +113.70% | 521B | |
| -0.44% | +3.69% | +41.45% | +68.91% | 386B | |
| +0.55% | +0.70% | +59.02% | +44.62% | 364B | |
| -0.12% | +0.74% | +28.39% | +58.54% | 302B | |
| +0.37% | +0.37% | +3.33% | +37.27% | 287B | |
| -0.30% | +1.14% | +38.29% | +72.46% | 252B | |
| +0.08% | +0.71% | +34.44% | +124.95% | 208B | |
| Average | -0.31% | +1.52% | +33.16% | +73.71% | 430B | |
| Weighted average by Cap. | +0.53% | +3.25% | +37.68% | +96.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 439M 398M 368M 332M 626M 41.41B 648M 4.42B 1.75B 22.12B 1.65B 1.61B 70.21B | 538M 487M 451M 407M 766M 50.68B 793M 5.41B 2.15B 27.07B 2.02B 1.97B 85.94B |
| Net income | -213M -193M -179M -161M -304M -20.13B -315M -2.15B -852M -10.75B -801M -784M -34.13B | -218M -198M -183M -165M -311M -20.57B -322M -2.2B -871M -10.99B -819M -801M -34.88B |
| Net Debt | -639M -579M -535M -483M -910M -60.22B -942M -6.43B -2.55B -32.17B -2.4B -2.35B -102B | -474M -429M -397M -358M -675M -44.68B -699M -4.77B -1.89B -23.87B -1.78B -1.74B -75.76B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-13 | $24.60 | -5.53% | 1,224,364 |
| 26-11-12 | $26.04 | -1.44% | 859,415 |
| 26-11-11 | $26.42 | -0.04% | 920,477 |
| 26-11-10 | $26.43 | -1.60% | 1,531,721 |
| 26-11-09 | $26.86 | +5.42% | 2,102,592 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ZLAB Stock
Select your edition
All financial news and data tailored to specific country editions
